Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,078,928 | 6,010,368 | 5,171,015 | 4,939,970 | 6,636,904 |
| Marketable Securities | 295,320 | 638,450 | 363,066 | 188,165 | 332,049 |
| Receivables | 9,787,933 | 9,530,781 | 8,879,089 | 8,065,310 | 8,473,335 |
| Inventories | 7,698,864 | 7,593,724 | 7,309,365 | 7,161,862 | 6,914,741 |
| Other current assets | 136,105 | 1,114,737 | 871,625 | 145,633 | 291,392 |
| TOTAL | $25,997,150 | $24,888,060 | $22,594,160 | $20,500,940 | $22,648,420 |
| Non-Current Assets | |||||
| PPE Net | 13,065,980 | 13,213,360 | 14,760,220 | 13,996,370 | 14,648,080 |
| Investments And Advances | 4,402,836 | 2,878,133 | 2,171,719 | 1,429,279 | 1,691,414 |
| Intangibles | 51,900,570 | 53,013,060 | 30,688,387 | 30,023,889 | 33,531,474 |
| Other Non-Current Assets | 7,906,864 | 7,766,107 | 7,292,014 | 6,713,352 | 7,553,092 |
| TOTAL | $77,276,250 | $76,870,660 | $54,912,340 | $52,162,890 | $57,424,060 |
| Total Assets | $103,273,400 | $101,758,700 | $77,506,500 | $72,663,840 | $80,072,480 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,782,900 | 8,833,594 | 7,732,497 | 3,640,860 | 5,596,034 |
| Accounts payable and accrued liabilities | 20,338,560 | 19,075,610 | 18,736,590 | 27,026,140 | 16,214,810 |
| Accrued Expenses | 699,780 | 803,170 | 1,288,082 | 1,282,356 | 1,768,667 |
| Other current liabilities | 2,616,792 | 1,997,072 | 2,263,821 | 2,292,775 | 2,172,546 |
| TOTAL | $28,438,030 | $30,709,450 | $30,020,990 | $34,242,130 | $25,752,050 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,077,700 | 30,122,070 | 27,057,730 | 18,383,440 | 19,870,050 |
| Other Non-Current Liabilities | 12,597,324 | 11,826,642 | 13,418,741 | 12,921,509 | 24,899,575 |
| TOTAL | $48,117,900 | $47,609,210 | $42,584,120 | $33,925,080 | $47,594,070 |
| Total Liabilities | $76,555,930 | $78,318,660 | $72,605,110 | $68,167,210 | $73,346,130 |
| Shareholders' Equity | |||||
| Common Shares | 1,728,264 | 1,718,707 | 1,795,306 | 1,730,858 | 1,818,813 |
| Retained earnings | 8,673,420 | 5,784,357 | -2,852,468 | -8,347,558 | -7,307,778 |
| Other shareholders' equity | 12,102,982 | 11,884,105 | 1,832,681 | 7,222,436 | 8,211,763 |
| TOTAL | $26,717,470 | $23,440,050 | $4,901,386 | $4,496,623 | $6,726,354 |
| Total Liabilities And Equity | $103,273,400 | $101,758,710 | $77,506,496 | $72,663,833 | $80,072,484 |